Are oestrogen deficiency and hormone replacement a distraction to the field of osteoporosis?
Kanis
J A
JA
Centre for Metabolic Bone Diseases at Sheffield (WHO Collaborating Center), University of Sheffield, UK.
D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D015519:Bone Density; D002318:Cardiovascular Diseases / Q000517:prevention & control; D015914:Estrogen Replacement Therapy; D004967:Estrogens / Q000008:administration & dosage / Q000172:deficiency*; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control; D006620:Hip Fractures / Q000209:etiology; D006801:Humans; D008297:Male; D008593:Menopause; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications; D015663:Osteoporosis, Postmenopausal / Q000503:physiopathology / Q000517:prevention & control*; D012307:Risk Factors
D004967:Estrogens